AURX 8-K 2026-10-06

Nuo Therapeutics, Inc. (AURX) 8-K dated 2026-10-06 — accession 0001437749-26-032242. This URL is the filing, not the AURX hub.

Nuo Therapeutics, Inc. (AURX) is a biotechnology company listed on US.

Nuo Therapeutics, Inc. filed a 8-K on 2026-10-06. Accession 0001437749-26-032242.

Cached items: 1.01, 2.03, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AURX revenue for 2025-12-31 was $3.3M. Net income was -$2.5M. Revenue was up 142.7% from 2024-12-31 to 2025-12-31. AURX currently screens at market cap $72.1M.

Not investment advice. The AURX SEC hub lists recent forms. The stock page is the research view.